Role of Rauvolfia serpentina mother tincture in Hypertentio
Not Applicable
- Conditions
- Health Condition 1: I00-I99- Diseases of the circulatory system
- Registration Number
- CTRI/2020/03/024231
- Lead Sponsor
- Dr Varsha Ghate
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with mild essential hypertension who are willing to participate and give informed conscent
Exclusion Criteria
secondary hypertension, pregnancy, lactation, allergic to reserpine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in systolic and diastolic blood pressureTimepoint: After seven to fifteen days
- Secondary Outcome Measures
Name Time Method other standardization parameters of mother tinctureTimepoint: one month